Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Toshiko Koue
Observed name:
Toshiko KOUE
Institution:
Bayer (Japan)
Observed institutions:
Otsuka (Japan),
Tokyo Medical and Dental University,
Kyoto University,
Eli Lilly (Japan),
Kyoto University Hospital,
Bayer (Japan),
University of Toyama
show all 7
OpenAlex ID:
A5020708708
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
2016
·
Kiyotaka Yoh
, Yukio Hosomi
, et al.
·
Lung Cancer
·
119
PDF
Influence of Itraconazole Co-administration and CYP2D6 Genotype on the Pharmacokinetics of the New Antipsychotic ARIPIPRAZOLE
2005
·
Masanori Kubo
, Toshiko Koue
, et al.
·
Drug Metabolism and Pharmacokinetics
·
91
Pharmacokinetics of Aripiprazole, a New Antipsychotic, following Oral Dosing in Healthy Adult Japanese Volunteers: Influence of CYP2D6 Polymorphism
2007
·
Masanori Kubo
, Toshiko Koue
, et al.
·
Drug Metabolism and Pharmacokinetics
·
81
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
2011
·
Junichi Azuma
, Tomoko Hasunuma
, et al.
·
European Journal of Clinical Pharmacology
·
55
PDF
Population Pharmacokinetics of Phenytoin in Japanese Patients with Epilepsy: Analysis with a Dose-Dependent Clearance Model.
1996
·
Atsuko ODANI
, Yukiya HASHIMOTO
, et al.
·
Biological and Pharmaceutical Bulletin
·
49
PDF
Prediction of Interindividual Variability in Pharmacokinetics for CYP3A4 Substrates in Humans
2010
·
Motohiro Kato
, Koji Chiba
, et al.
·
Drug Metabolism and Pharmacokinetics
·
43
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study
2018
·
Kensei Yamaguchi
, Kazumasa Fujitani
, et al.
·
Gastric Cancer
·
21
PDF
Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Aripiprazole in Healthy Japanese Males
2007
·
Toshiko Koue
, Masanori Kubo
, et al.
·
Biological and Pharmaceutical Bulletin
·
15
PDF
Simulation for population analysis of Michaelis-Menten elimination kinetics
1995
·
Yukiya Hashimoto
, Toshiko Koue
, et al.
·
Journal of Pharmacokinetics and Biopharmaceutics
·
13
Simulation for the Analysis of Distorted Pharmacodynamic Data
1994
·
Yukiya Hashimoto
, Junko Ozaki
, et al.
·
Pharmaceutical Research
·
9
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
2021
·
Masaru Hirano
, Masanori Yamada
, et al.
·
Clinical Pharmacology in Drug Development
·
8
Population Pharmacokinetic Analysis of Mexiletine in Adult Arrhythmic Patients in Japanese Population.
1998
·
Kazunori UENAKA
, Toshiko KOUE
, et al.
·
Biological and Pharmaceutical Bulletin
·
5
PDF
Cyp2d6遺伝子型によるアリピプラゾールの薬物動力学ーcyp3a4の代謝性関与およびコルチゾール代謝との関連性ー | 文献情報 | J-global 科学技術総合リンクセンター
2008
·
Masanori KUBO
, Toshiko Koue
, et al.
·
The Japanese Society for the Study of Xenobiotics
The relationship between the pharmacokinetics of a new antipsychotic, aripiprazole, and CYP2D6 genetic polymorphism in healthy adult volunteers
2005
·
Masanori KUBO
, Toshiko Koue
, et al.
·
The Keio Journal of Medicine
Show more works
View as search
Works count:
14
Citation count:
509
H-index:
9
I10-index:
9
Year
Topic
Type